The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(21)00025-5
PubMed Identifier: 33770513
Publication URI: http://europepmc.org/abstract/MED/33770513
Type: Journal Article/Review
Volume: 9
Parent Publication: The Lancet. Global health
Issue: 5
ISSN: 2214-109X